Meeting
2015 ASCO Annual Meeting
Identification of novel and potentially targetable receptor tyrosine kinase alterations in colorectal carcinoma using a 341 gene hybrid capture-based next-generation sequencing assay.
Authors
Jaclyn Frances Hechtman
Memorial Sloan Kettering Cancer Center, New York, NY
Jaclyn Frances Hechtman , Maria E. Arcila , Donavan T. Cheng , David B. Solit , Rona D. Yaeger , David Michael Hyman , Michael F. Berger , Jinru Shia , Efsevia Vakiani , Ahmet Zehir , Marc Ladanyi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Citation
J Clin Oncol 33, 2015 (suppl; abstr 11071)
DOI
10.1200/jco.2015.33.15_suppl.11071
Abstract #
11071
Poster Bd #
285
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in “pan-negative” lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history.
First Author: Alexander E. Drilon
Poster
2018 Gastrointestinal Cancers Symposium
Comprehensive genomic profiling of appendiceal adenocarcinoma.
First Author: Kanwal Pratap Singh Raghav
Poster
2014 ASCO Annual Meeting
Impact of next-generation sequencing (NGS) on treatment decisions in the community oncology setting.
First Author: Lindsay Carol Overton
Poster
2013 ASCO Annual Meeting
Multiplexed genetic analysis of malignant pleural mesothelioma and the relationship to clinical outcome.
First Author: Takehito Shukuya